Developed the first genomic test for personalized HER2+ breast cancer treatments
The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.
The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.
Ten IDIBAPS groups are looking for candidates to apply for one of the 35 pre-doctoral scholarships offered by the INPhINIT Incoming program of the La1
Researchers at Hospital Clínic-IDIBAPS are leading the CIBERESUCICOVID project, which seeks to identify the risk and prognosis factors of patients wi1
Dr. Josep Baselga, an internationally renowned medical oncologist, died of this degenerative disease on 21 March 2021. The meeting was attended by Dr1
The study shows how the average life of the virus is drastically reduced, in transplanted patients and cell cultures alike.
The inhibition of this molecule, in addition to reducing the predisposition towards developing the disease, also reduces the alteration of the microb1
The researcher has received a runner’s-up prize in the Dr. Font Prize category, which recognises the best research articles published, with potential1
On Friday, 26 November, the dissemination seminar "Immunotherapy 2.0 in lymphoma: how to design personalized therapies" for patients and relatives wa1
The Hospital Clínic-IDIBAPS researcher has been awarded in the basic research category.
On Tuesday 16 November and Wednesday 17 November, school-leaving students and students in higher education took part in the open-air science workshop1